| 1 |
DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014 [J]. CA Cancer J Clin, 2014, 64(4): 252-271.
|
| 2 |
Zamorano JL, Lancellotti P, Rodriguez Munoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2016, 37(36): 2768-2801.
|
| 3 |
Plana JC, Galderisi M, Barac A, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging [J]. J Am Soc Echocardiogr, 2014, 27(9): 911-939.
|
| 4 |
Zhang S, Liu X, Bawa-Khalfe T, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity [J]. Nat Med, 2012, 18(11): 1639-1642.
|
| 5 |
Ewer MS, Lippman SM. Type Ⅱ chemotherapy-related cardiac dysfunction: time to recognize a new entity [J]. J Clin Oncol, 2005, 23(13): 2900-2902.
|
| 6 |
Thavendiranathan P, Grant AD, Negishi T, et al. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy [J]. J Am Coll Cardiol, 2013, 61(1): 77-84.
|
| 7 |
Bountioukos M, Doorduijn JK, Roelandt JR, et al. Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity [J]. Eur J Echocardiogr, 2003, 4(4): 300-305.
|
| 8 |
Karakurt C, Kocak G, Ozgen U. Evaluation of the left ventricular function with tissue tracking and tissue Doppler echocardiography in pediatric malignancy survivors after anthracycline therapy [J]. Echocardiography, 2008, 25(8): 880-887.
|
| 9 |
Tassan-Mangina S, Codorean D, Metivier M, et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study [J]. Eur J Echocardiogr, 2006, 7(2): 141-146.
|
| 10 |
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging [J]. J Am Soc Echocardiogr, 2016, 29(4): 277-314.
|
| 11 |
Tanindi A, Demirci U, Tacoy G, et al. Assessment of right ventricular functions during cancer chemotherapy [J]. Eur J Echocardiogr, 2011, 12(11): 834-840.
|
| 12 |
Cardinale D, Colombo A, Lamantia G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy [J]. J Am Coll Cardiol, 2010, 55(3): 213-220.
|
| 13 |
Rohde LE, Baldi A, Weber C, et al. Tei index in adult patients submitted to adriamycin chemotherapy: failure to predict early systolic dysfunction. Diagnosis of adriamycin cardiotoxicity [J]. Int J Cardiovasc Imaging, 2007, 23(2): 185-191.
|
| 14 |
Thavendiranathan P, Poulin F, Lim KD, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review [J]. J Am Coll Cardiol, 2014, 63(25 Pt A): 2751-2768.
|
| 15 |
Negishi K, Negishi T, Hare JL, et al. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity [J]. J Am Soc Echocardiogr, 2013, 26(5): 493-498.
|
| 16 |
Byrd BF, 3rd. A unique collaboration to advance strain imaging [J]. J Am Soc Echocardiogr, 2013, 26(11): 21A-22A.
|
| 17 |
Yu W, Li SN, Chan GC, et al. Transmural strain and rotation gradient in survivors of childhood cancers [J]. Eur Heart J Cardiovasc Imaging, 2013, 14(2): 175-182.
|
| 18 |
Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging [J]. Eur Heart J Cardiovasc Imaging, 2013, 14(7): 611-644.
|
| 19 |
Gaya AM, Ashford RF. Cardiac complications of radiation therapy [J]. Clin Oncol (R Coll Radiol), 2005, 17(3): 153-159.
|
| 20 |
Krupicka J, Markova J, Pohlreich D, et al. Echocardiographic evaluation of acute cardiotoxicity in the treatment of Hodgkin disease according to the German Hodgkin′s Lymphoma Study Group [J]. Leuk Lymphoma, 2002, 43(12): 2325-2329.
|
| 21 |
Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography [J]. J Am Soc Echocardiogr, 2013, 26(9): 965-1012. e15.
|
| 22 |
Senior R, Becher H, Monaghan M, et al. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography [J]. Eur J Echocardiogr, 2009, 10(2): 194-212.
|
| 23 |
Civelli M, Cardinale D, Martinoni A, et al. Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity [J]. Int J Cardiol, 2006, 111(1): 120-126.
|
| 24 |
Jensen BV, Skovsgaard T, Nielsen SL. Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients [J]. Ann Oncol, 2002, 13(5): 699-709.
|
| 25 |
Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction [J]. N Engl J Med, 2000, 343(20): 1445-1453.
|
| 26 |
Cardinale D, Sandri MT, Colombo A, et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy [J]. Circulation, 2004, 109(22): 2749-2754.
|